Asia-Pacific Tuberculosis Diagnosis and Treatment Market Growth, Size, Share, Industry Report and Forecast 2019-2025
Asia-Pacific tuberculosis diagnosis and treatment market is anticipated to grow at a CAGR around 2.8% during the forecast period. Largest number of new TB cases was reported in Asia accounting for 45% of new cases. Tuberculosis incidence, and mortality rate was comparatively higher in countries with lower human development index, gross domestic product (GDP) per capita, corruption perception index and countries with more people under minimum food supplements. Among the health system variables, governmental health expenditure per capita, total health expenditure per capita, access to improved water, hospital beds and sanitation are strongly associated with tuberculosis. As Asia is the region with most of the developing countries, unavailability of these system variables increases the incidences of tuberculosis in the Asia-pacific.
To Request a Sample of our Report on Asia-Pacific
Tuberculosis Diagnosis and Treatment Market: https://www.omrglobal.com/request-sample/asia-pacific-tuberculosis-diagnosis-and-treatment-market
USAID has supported TB control and prevention in the Asia-Pacific
region. Its major goal is the development as well as implementation of
innovative and scalable programs for TB control in the Asia-Pacific region. The
organization has been focusing on building comprehensive models to improve
diagnosis, MDR-TB prevention, and treatment initiation, along with treatment
success. USAID support strengthens national TB programs by assisting them and
introducing innovative and cost-effective approaches to TB control. USAID along
with countries government initiatives has been the major factor in the market
growth.
Asia-Pacific tuberculosis diagnosis and treatment market is segmented on the basis of drugs type and diagnosis. Based on drug type, the market is segmented into first line drugs and second line drugs. Based on diagnosis, the market is segmented into laboratory testing, nucleic acid amplification test, mantoux test, radiography and drug susceptibility testing.
A
full Report of Asia-Pacific Tuberculosis Diagnosis and Treatment Market is
Available at:
https://www.omrglobal.com/industry-reports/asia-pacific-tuberculosis-diagnosis-and-treatment-market
Asia-Pacific Tuberculosis
Diagnosis and Treatment Market
Segmentation
·
First Line Drugs
·
Second Line Drugs
By Diagnosis
·
Laboratory
Testing
·
Nucleic
Acid Amplification Test
·
Mantoux
Test
·
Radiography
·
Drug
Susceptibility Testing
Regional
Analysis
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Company
Profiles
·
Abbott
Laboratories
·
Becton,
Dickinson and Co.
·
Biochemical
and Synthetic Products Pvt Ltd.
·
Eiken
Chemical Co., Ltd.
·
F.
Hoffmann-La Roche Ltd.
·
GlaxoSmithKline
PLC
·
Labatec
Pharma SA
·
Lupin
Pharmaceuticals, Inc.
·
Thermo
Fisher Scientific
Reasons to Buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data, Request for
Report Customization @ https://www.omrglobal.com/report-customization/asia-pacific-tuberculosis-diagnosis-and-treatment-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
For
More Information, Visit Orion Market Research
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment